Great West Life Assurance CO Zymeworks Inc. Transaction History

Great West Life Assurance CO

  • $57.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$4.82 - $7.7 $8,140 - $13,005
-1,689 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$26.5 - $38.23 $21,385 - $30,851
-807 Reduced 32.33%
1,689 $59,000
Q2 2020

Aug 17, 2020
BUY
$33.67 - $40.0 $84,040 - $99,840
2,496 New
2,496 $90,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $872M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email